SYNTHESIS AND EVALUATION OF PROTACS TO ENABLE RAD52 DEGRADATION FOR OVARIAN CANCER THERAPY: A SYNTHETIC LETHALITY APPROACH
$695,250FY2025Defense Health AgencyDOD
Board Of Regents Of The University Of Nebraska
Board Of Regents Of The University Of Nebraska